Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer

Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer

Abstract Background Basal-like breast cancer (BLBC) is a poorly characterised, heterogeneous disease. Patients are diagnosed with aggressive, high-grade tumours and often relapse with chemotherapy resistance. Detailed understanding of the molecular underpinnings of this disease is essential to the d...

Full description

Bibliographic Details
Main Authors: Laura A. Baker, Holly Holliday, Daniel Roden, Christoph Krisp, Sunny Z. Wu, Simon Junankar, Aurelien A. Serandour, Hisham Mohammed, Radhika Nair, Geetha Sankaranarayanan, Andrew M. K. Law, Andrea McFarland, Peter T. Simpson, Sunil Lakhani, Eoin Dodson, Christina Selinger, Lyndal Anderson, Goli Samimi, Neville F. Hacker, Elgene Lim, Christopher J. Ormandy, Matthew J. Naylor, Kaylene Simpson, Iva Nikolic, Sandra O’Toole, Warren Kaplan, Mark J. Cowley, Jason S. Carroll, Mark Molloy, Alexander Swarbrick
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Breast Cancer Research
Subjects:
Breast cancer
Transcription factor
Helix-loop-helix
DNA damage
Online Access:http://link.springer.com/article/10.1186/s13058-020-01306-6

Internet

http://link.springer.com/article/10.1186/s13058-020-01306-6

Similar Items